Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 52, 2022 - Issue 1
171
Views
4
CrossRef citations to date
0
Altmetric
Animal Pharmacokinetics and Metabolism

Absorption, distribution, metabolism, and excretion of [14C]TPN729 after oral administration to rats

, , , , , , , , , , & show all
Pages 79-90 | Received 03 Nov 2021, Accepted 13 Jan 2022, Published online: 27 Jan 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xinyu Ge, Sheng Ma, Shu Yan, Yali Wu, Chong Chen, Chongzhuang Tang, Yan Zhan, Yi-cong Bian, Kai Shen, Sheng Feng, Xuehu Gao, Dafang Zhong, Hua Zhang, Li-yan Miao & Xing-xing Diao. (2023) Mass balance study of [14C]SHR0302, a selective and potent JAK1 inhibitor in humans. Xenobiotica 53:2, pages 69-83.
Read now

Articles from other publishers (3)

Xinyue Zhang, Donghui Liu, Ming Lu, Yali Yuan, Chen Yang, Ying Yang, Jin Xiu, Pingsheng Hu, Yuandong Zheng & Xingxing Diao. (2024) Absorption, distribution, metabolism and excretion of linaprazan glurate in rats. Journal of Pharmaceutical and Biomedical Analysis 242, pages 116012.
Crossref
Xinyu Ge, Yuandong Zheng, Yifei He, Chong Chen, Chen Yang, Saiwei Lu, Zhenyu Xuan, Dafang Zhong & Xingxing Diao. (2023) Pharmacokinetics, Mass Balance, Tissue Distribution, and Metabolism of [3H]Catalpol in Rats: the Main Bioactive Component of Rehmannia glutinosa for the Treatment of Ischemic Stroke. Current Drug Metabolism 24:6, pages 448-457.
Crossref
Xin-mei Li, Yuan-dong Zheng, Yi-fan Zhang, Xia-juan Huan, Chen Yang, Meng-ling Liu, Xiao-kun Shen, Chun-hao Yang & Xing-xing Diao. (2022) Absorption, distribution, metabolism, and excretion of [14C]Mefuparib (CVL218), a novel PARP1/2 inhibitor, in rats. Cancer Chemotherapy and Pharmacology 90:6, pages 499-510.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.